X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2239) 2239
male (1707) 1707
neurosciences (1536) 1536
rats (1508) 1508
periaqueductal gray (1067) 1067
index medicus (1053) 1053
periaqueductal gray - metabolism (698) 698
rats, sprague-dawley (684) 684
rats, wistar (505) 505
female (477) 477
periaqueductal gray - drug effects (441) 441
pharmacology & pharmacy (419) 419
neurons (406) 406
neurons - metabolism (395) 395
humans (386) 386
brain (368) 368
mice (355) 355
pain (355) 355
immunohistochemistry (350) 350
rat (349) 349
periaqueductal gray - physiology (279) 279
anxiety (266) 266
brain - metabolism (257) 257
article (253) 253
analgesia (243) 243
dose-response relationship, drug (231) 231
morphine (228) 228
proto-oncogene proteins c-fos - metabolism (228) 228
nervous system (221) 221
neurology (219) 219
disease models, animal (218) 218
spinal-cord (217) 217
neurons - drug effects (211) 211
serotonin (206) 206
clinical neurology (197) 197
morphine - pharmacology (196) 196
behavioral sciences (194) 194
central-nervous-system (193) 193
microinjections (191) 191
pain - physiopathology (190) 190
gaba (184) 184
antinociception (182) 182
pain - metabolism (182) 182
periaqueductal gray - cytology (182) 182
midbrain periaqueductal gray (180) 180
endocrinology & metabolism (177) 177
serotonin - metabolism (176) 176
behavior, animal - drug effects (174) 174
c-fos (174) 174
analysis of variance (170) 170
analgesics, opioid - pharmacology (169) 169
psychiatry (169) 169
rat-brain (167) 167
time factors (164) 164
amygdala (163) 163
neurons - physiology (161) 161
brain-stem (156) 156
stress (156) 156
rostral ventromedial medulla (148) 148
electrical-stimulation (145) 145
rodents (144) 144
pain measurement (143) 143
gamma-aminobutyric acid - metabolism (140) 140
glutamate (140) 140
neuropathic pain (137) 137
physiological aspects (131) 131
receptors, opioid, mu - metabolism (130) 130
analysis (129) 129
nociception (127) 127
spinal cord - metabolism (126) 126
hypothalamus (124) 124
biochemistry & molecular biology (123) 123
periaqueductal grey (123) 123
neural pathways - metabolism (118) 118
physiology (118) 118
narcotic antagonists - pharmacology (116) 116
electric stimulation (115) 115
pain - drug therapy (115) 115
periaqueductal gray-matter (115) 115
behavior, animal - physiology (114) 114
elevated plus-maze (114) 114
naloxone - pharmacology (113) 113
neural pathways - physiology (113) 113
nucleus raphe magnus (113) 113
receptors (112) 112
analgesics - pharmacology (111) 111
expression (109) 109
neurons - cytology (108) 108
dorsal periaqueductal gray (107) 107
cats (105) 105
periaqueductal gray area (105) 105
brain - drug effects (103) 103
research (103) 103
rats, inbred strains (102) 102
behavior (101) 101
mice, inbred c57bl (99) 99
stimulation (99) 99
zoology (99) 99
brain mapping (97) 97
messenger-rna (97) 97
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2439) 2439
Chinese (20) 20
Russian (5) 5
Japanese (2) 2
Spanish (2) 2
German (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuropharmacology, ISSN 0028-3908, 06/2016, Volume 105, pp. 577 - 586
The orexin system consists of orexin A/hypocretin 1 and orexin B/hypocretin 2, and OX1 and OX2 receptors. Our previous electrophysiological study showed that... 
Periaqueductal gray | Pain | OX1 and OX2 receptors | Cannabinoid | Orexin | Stress-induced analgesia | PROTEIN | RAT | INVOLVEMENT | LATERAL HYPOTHALAMUS STIMULATION | ANTINOCICEPTION | NEUROSCIENCES | VENTRAL TEGMENTAL AREA | HYPOCRETIN OREXIN | NUCLEUS-ACCUMBENS | NEURONS | PHARMACOLOGY & PHARMACY | EXPRESSION | Benzoxazoles - pharmacology | Neurons - pathology | Pain Perception - physiology | Periaqueductal Gray - drug effects | Analgesics, Opioid - pharmacology | Male | Nociceptive Pain - drug therapy | Nociceptive Pain - metabolism | Isoquinolines - pharmacology | Pain Perception - drug effects | Receptor, Cannabinoid, CB1 - agonists | Stress, Psychological - metabolism | Urea - analogs & derivatives | Neurons - metabolism | Corticosterone - blood | Hypothalamus - drug effects | Neurons - drug effects | Orexin Receptors - metabolism | Stress, Psychological - drug therapy | Mice, Inbred C57BL | Nociceptive Pain - pathology | Proto-Oncogene Proteins c-fos - metabolism | Morpholines - pharmacology | Hypothalamus - pathology | Periaqueductal Gray - metabolism | Naphthalenes - pharmacology | Stress, Psychological - pathology | Receptor, Cannabinoid, CB1 - metabolism | Animals | Hypothalamus - metabolism | Signal Transduction - drug effects | Naloxone - pharmacology | Benzoxazines - pharmacology | Orexin Receptors - agonists | Pyridines - pharmacology | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Periaqueductal Gray - pathology | Urea - pharmacology | Physiological aspects | Medical colleges | Analgesia
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 2018, Volume 43, Issue 2, pp. 302 - 312
The mechanisms underlying chronic stress-induced dysfunction of glutamatergic transmission that contribute to helplessness-associated depressive disorder are... 
PSYCHIATRY | BEHAVIOR | COGNITIVE IMPAIRMENT | NERVE-INJURY | SYNAPTIC PLASTICITY | NEUROSCIENCES | PREFRONTAL CORTEX | KETAMINE | NEUROPATHIC PAIN | AMPA RECEPTORS | LEARNED HELPLESSNESS MODEL | PHARMACOLOGY & PHARMACY | MODULATION | Depression - physiopathology | Receptors, Glucocorticoid - antagonists & inhibitors | Synaptic Transmission - physiology | gamma-Aminobutyric Acid - metabolism | Periaqueductal Gray - drug effects | Male | Receptors, Glucocorticoid - agonists | Depression - etiology | Depression - metabolism | Depression - chemically induced | Stress, Psychological - metabolism | Behavior, Animal - drug effects | Synaptic Transmission - drug effects | Anhedonia - physiology | Receptors, AMPA - metabolism | Disease Models, Animal | Rats | Behavior, Animal - physiology | Rats, Sprague-Dawley | Periaqueductal Gray - metabolism | Periaqueductal Gray - physiopathology | Patch-Clamp Techniques | Animals | Glutamic Acid - metabolism | Stress, Psychological - complications | Receptors, AMPA - antagonists & inhibitors | Sucrose | Mental disorders | Glucocorticoids | Glutamic acid receptors (ionotropic) | Pathogenesis | Foot shock | Glutamic acid receptors | Mental depression | α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors | Cell surface | Western blotting | Receptors | Reduction | γ-Aminobutyric acid | Endocytosis | Synaptic transmission | α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid | Hedonic response | Sugars | Stresses | Periaqueductal gray area | Pharmacology | Stress | Behavioral despair | Acids | Glutamatergic transmission | Original
Journal Article
Neuron, ISSN 0896-6273, 03/2015, Volume 85, Issue 6, pp. 1344 - 1358
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 01/2009, Volume 29, Issue 2, pp. 340 - 358
Journal Article
NeuroImage: Clinical, ISSN 2213-1582, 2014, Volume 6, Issue C, pp. 100 - 108
Chronic low back pain is a common neurological disorder. The periaqueductal gray (PAG) plays a key role in the descending modulation of pain. In this study, we... 
Functional connectivity | fMRI | Periaqueductal gray | Chronic low back pain | RESTING-STATE FMRI | NETWORK | SPONTANEOUS FLUCTUATIONS | PLACEBO ANALGESIA | GLOBUS-PALLIDUS | HUMANS | NEUROIMAGING | ELECTRICAL-STIMULATION | CORTEX | BRAIN | MODULATION
Journal Article
Journal Article